With a generous donation from the Li Ka Shing Foundation, the LKS Faculty of Medicine at the University of Hong Kong will be the first institution in Asia to introduce the groundbreaking Histotripsy system, using state-of-the-art histotripsy technology for clinical trials, offering Hong Kong liver cancer patients access to non-invasive, painless and highly effective treatment.
[The University of Hong Kong]